The expressions of PTPN21 and CALB1 were significantly elevated, while the expressions of C1orf105, CCL22, CRYGB, FRK, GAP43, and REG1P were significantly decreased in the CAD samples of the merged dataset (Supplementary Figure S2). This evidence concerns the gene CALB1 and coronary artery disorder.